Wanyi Technology: the net profit in the first three quarters increased by 286.04% to 5.2454 million yuan
Cailian news agency, October 27 - Wanyi technology announced that in the first three quarters of 2021, the company achieved an operating revenue of 346 million yuan, a year-on-year increase of 53.61%; The net profit attributable to the shareholders of the listed company was 5.2454 million yuan, a year-on-year increase of 286.04%; The net loss attributable to the shareholders of the listed company after deducting non recurring profits and losses was 12.7073 million yuan; The basic earnings per share is 0.04 yuan / share.
This text is a result of machine translation.
Related companies：
Briefing Updated 47 mins ago
· Healthcare
Tianyu Information: 30538103 shares held by the controlling shareholder were frozen by the judiciary
Briefing Updated 37 mins ago
· Healthcare
Drug Tesco: it plans to participate in the bidding for 45% equity of Sichuan famous doctors
In depth
Healthcare
Jiangsu Hengrui, Chinese Cancer Drugmaker Emerging from the Shadows
A flagship in the Chinese oncology market, Jiangsu Hengrui Medicine (600276:SH) was accused of corruption in sales. This was soon followed by good news – an approval of a Phase III clinical test. Will a bright future erase the black stain?
May 22, 2020 10:52 PM
Apr 22, 2021 03:11 PM
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Aug 09, 2020 12:23 AM
Healthcare
Yunnan Baiyao's Revenue Rises 33%; Net Profit Falls 40% in 1Q 2021
On April 27, Yunnan Baiyao released a report for the first quarter of 2021 showing that the company's total operating revenue for the first quarter was 10.33 billion yuan, up 33.4% year-on-year; its operating profit was 880 million yuan, down 41.8% year-on-year; its net profit attributable to shareholders of the listed company was 760 million yuan.
Apr 30, 2021 02:07 AM
Briefing Oct 30, 2021 07:57 AM
· Healthcare
Economic Daily: enterprise investment should not abandon the main business
Briefing Oct 28, 2021 03:23 PM
· Healthcare
Yunnan Baiyao responded that it lost 1.5 billion in stock speculation: it will gradually optimize the structure and gradually withdraw from securities investment
Briefing Aug 30, 2021 08:46 AM
· Healthcare
August 30 stock market lightning rod
In depth
Healthcare
Yunnan Baiyao: An Oriental Mystery in the Limelight (2/2)
Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.
May 19, 2020 12:30 PM
In depth
Healthcare
Yunnan Baiyao: An Oriental Mystery in the Limelight (1/2)
Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.
May 19, 2020 12:00 PM
Briefing Jul 07, 2021 03:24 PM
· Healthcare
The first bank of China fund to release its second Quarterly Report
Briefing Updated 2 hours ago
· Healthcare
The official results of intensive insulin purchase were announced: the average drop was 48%, and it is expected to save 9 billion yuan per year
See more
Read next
Consumer Discretionary · Analysis
New Oriental Education's Pivot from Overregulated K-12 Industry Is Worth a Bet
Nov 25, 2021 06:18 PM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.